Literature DB >> 12242300

Calreticulin interacts with C/EBPalpha and C/EBPbeta mRNAs and represses translation of C/EBP proteins.

Lubov T Timchenko1, Polina Iakova, Alana L Welm, Z-J Cai, Nikolai A Timchenko.   

Abstract

We previously identified an RNA binding protein, CUGBP1, which binds to GCN repeats located within the 5' region of C/EBPbeta mRNAs and regulates translation of C/EBPbeta isoforms. To further investigate the role of RNA binding proteins in the posttranscriptional control of C/EBP proteins, we purified additional RNA binding proteins that interact with GC-rich RNAs and that may regulate RNA processing. In HeLa cells, the majority of GC-rich RNA binding proteins are associated with endogenous RNA transcripts. The separation of these proteins from endogenous RNA identified several proteins in addition to CUGBP1 that specifically interact with the GC-rich 5' region of C/EBPbeta mRNA. One of these proteins was purified to homogeneity and was identified as calreticulin (CRT). CRT is a multifunctional protein involved in several biological processes, including interaction with and regulation of rubella virus RNA processing. Our data demonstrate that both CUGBP1 and CRT interact with GCU repeats within myotonin protein kinase and with GCN repeats within C/EBPalpha and C/EBPbeta mRNAs. GCN repeats within these mRNAs form stable SL structures. The interaction of CRT with SL structures of C/EBPbeta and C/EBPalpha mRNAs leads to inhibition of translation of C/EBP proteins in vitro and in vivo. Deletions or mutations abolishing the formation of SL structures within C/EBPalpha and C/EBPbeta mRNAs lead to a failure of CRT to inhibit translation of C/EBP proteins. CRT-dependent inhibition of C/EBPalpha is sufficient to block the growth-inhibitory activity of C/EBPalpha. This finding further defines the molecular mechanism for posttranscriptional regulation of the C/EBPalpha and C/EBPbeta proteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12242300      PMCID: PMC139801          DOI: 10.1128/MCB.22.20.7242-7257.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  36 in total

1.  Expression of a translationally regulated, dominant-negative CCAAT/enhancer-binding protein beta isoform and up-regulation of the eukaryotic translation initiation factor 2alpha are correlated with neoplastic transformation of mammary epithelial cells.

Authors:  B Raught; A C Gingras; A James; D Medina; N Sonenberg; J M Rosen
Journal:  Cancer Res       Date:  1996-10-01       Impact factor: 12.701

2.  Ectopic expression of Hel-N1, an RNA-binding protein, increases glucose transporter (GLUT1) expression in 3T3-L1 adipocytes.

Authors:  R G Jain; L G Andrews; K M McGowan; P H Pekala; J D Keene
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

3.  Evidence for posttranscriptional regulation of C/EBPalpha and C/EBPbeta isoform expression during the lipopolysaccharide-mediated acute-phase response.

Authors:  M R An; C C Hsieh; P D Reisner; J P Rabek; S G Scott; D T Kuninger; J Papaconstantinou
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

4.  CUG repeat binding protein (CUGBP1) interacts with the 5' region of C/EBPbeta mRNA and regulates translation of C/EBPbeta isoforms.

Authors:  N A Timchenko; A L Welm; X Lu; L T Timchenko
Journal:  Nucleic Acids Res       Date:  1999-11-15       Impact factor: 16.971

5.  The rubella virus RNA binding activity of human calreticulin is localized to the N-terminal domain.

Authors:  C D Atreya; N K Singh; H L Nakhasi
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

6.  Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy.

Authors:  L T Timchenko; N A Timchenko; C T Caskey; R Roberts
Journal:  Hum Mol Genet       Date:  1996-01       Impact factor: 6.150

7.  Calreticulin binds hYRNA and the 52-kDa polypeptide component of the Ro/SS-A ribonucleoprotein autoantigen.

Authors:  S T Cheng; T Q Nguyen; Y S Yang; J D Capra; R D Sontheimer
Journal:  J Immunol       Date:  1996-06-01       Impact factor: 5.422

8.  Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy.

Authors:  L T Timchenko; J W Miller; N A Timchenko; D R DeVore; K V Datar; L Lin; R Roberts; C T Caskey; M S Swanson
Journal:  Nucleic Acids Res       Date:  1996-11-15       Impact factor: 16.971

9.  A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity.

Authors:  F T Lin; O A MacDougald; A M Diehl; M D Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

10.  Translation start site multiplicity of the CCAAT/enhancer binding protein alpha mRNA is dictated by a small 5' open reading frame.

Authors:  C F Calkhoven; P R Bouwman; L Snippe; G Ab
Journal:  Nucleic Acids Res       Date:  1994-12-25       Impact factor: 16.971

View more
  35 in total

1.  DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.

Authors:  Mirko Marabese; Faina Vikhanskaya; Cristina Rainelli; Toshiyuki Sakai; Massimo Broggini
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

2.  CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha.

Authors:  Steffen Koschmieder; Francesco D'Alò; Hanna Radomska; Christine Schöneich; Ji Suk Chang; Marina Konopleva; Susumu Kobayashi; Elena Levantini; Nanjoo Suh; Annalisa Di Ruscio; Maria Teresa Voso; Julie C Watt; Ramasamy Santhanam; Bülent Sargin; Hagop Kantarjian; Michael Andreeff; Michael B Sporn; Danilo Perrotti; Wolfgang E Berdel; Carsten Müller-Tidow; Hubert Serve; Daniel G Tenen
Journal:  Blood       Date:  2007-08-01       Impact factor: 22.113

3.  Regulation of C/EBPbeta isoforms by MAPK pathways in HL60 cells induced to differentiate by 1,25-dihydroxyvitamin D3.

Authors:  Ewa Marcinkowska; Edward Garay; Elzbieta Gocek; Agnieszka Chrobak; Xuening Wang; George P Studzinski
Journal:  Exp Cell Res       Date:  2006-04-19       Impact factor: 3.905

4.  Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells.

Authors:  Clara Guerzoni; Michela Bardini; Samanta A Mariani; Giovanna Ferrari-Amorotti; Paolo Neviani; Maria Luisa Panno; Ying Zhang; Robert Martinez; Danilo Perrotti; Bruno Calabretta
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

5.  Dystrophia myotonia: why focus on foci?

Authors:  R P Junghans
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

6.  Epidermal growth factor receptor stimulation activates the RNA binding protein CUG-BP1 and increases expression of C/EBPbeta-LIP in mammary epithelial cells.

Authors:  Brenda R Baldwin; Nikolai A Timchenko; Cynthia A Zahnow
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

7.  The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin.

Authors:  Daniel Helbling; Beatrice U Mueller; Nikolai A Timchenko; Anne Hagemeijer; Martine Jotterand; Sandrine Meyer-Monard; Andrew Lister; Janet D Rowley; Barbara Huegli; Martin F Fey; Thomas Pabst
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

Review 8.  C/EBPα in normal and malignant myelopoiesis.

Authors:  Alan D Friedman
Journal:  Int J Hematol       Date:  2015-03-10       Impact factor: 2.490

9.  Competition of CUGBP1 and calreticulin for the regulation of p21 translation determines cell fate.

Authors:  Polina Iakova; Guo-Li Wang; Lubov Timchenko; Marek Michalak; Olivia M Pereira-Smith; James R Smith; Nikolai A Timchenko
Journal:  EMBO J       Date:  2004-01-15       Impact factor: 11.598

10.  HDAC1 cooperates with C/EBPalpha in the inhibition of liver proliferation in old mice.

Authors:  Guo-Li Wang; Elizabeth Salisbury; Xiurong Shi; Lubov Timchenko; Estela E Medrano; Nikolai A Timchenko
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.